ADVANCED GENETICS RES INST has a total of 12 patent applications. Its first patent ever was published in 1983. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are PHILIPS ROXANE, MOLECULAR ENG ASS and RIT RECH IND THERAPEUT.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | United States | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | South Africa | 2 | |
#5 | Canada | 1 | |
#6 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Machines | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Unspecified technologies | |
#4 | Syringes | |
#5 | Object sterilising | |
#6 | Climate change adaptation technologies | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Wiesehahn Gary P | 10 |
#2 | Stevens David R | 5 |
#3 | Giles Richard E | 4 |
#4 | Lin Lily | 2 |
#5 | Botchan Michael R | 2 |
#6 | Giles R E | 1 |
#7 | Creagan Richard P | 1 |
#8 | Wiesehahn G P | 1 |
#9 | Weisehahn Gary P | 1 |
#10 | Stevens D R | 1 |
Publication | Filing date | Title |
---|---|---|
EP0213894A2 | Defective viral particle vaccines and methods for their use | |
US4693981A | Preparation of inactivated viral vaccines | |
EP0124363A2 | Photochemical decontamination treatment of whole blood or blood components | |
US4556556A | Vaccine for the prevention of vesicular stomatitis virus infection | |
US4545987A | Psoralen inactivated double-stranded RNA viral vaccines |